Stock Events

Stock Events

Delta-Fly Pharma 

¥121
1
+¥10+9.01% Friday 06:30

Statistics

Day High
123
Day Low
109
52W High
700
52W Low
92
Volume
2,274,900
Avg. Volume
592,623
Mkt Cap
1.59B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-43.47
-38.76
-34.04
-29.33
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-1.72BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited is a major player in the pharmaceutical industry in Japan, competing directly in various therapeutic areas with Delta-Fly Pharma.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. focuses on prescription pharmaceuticals, including those in the oncology and cardiovascular sectors, overlapping with Delta-Fly Pharma's market.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. is involved in the development of pharmaceutical solutions in neurology and oncology, areas that Delta-Fly Pharma may also be exploring.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited operates in the pharmaceutical sector, producing medicines that compete in the same therapeutic areas as Delta-Fly Pharma.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on niche areas within pharmaceuticals, including oncology and nephrology, potentially competing with Delta-Fly Pharma's product lines.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. manufactures and sells pharmaceuticals, including anti-infectives and drugs for chronic diseases, competing with Delta-Fly Pharma.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. is a global pharmaceutical company that develops and markets drugs in several therapeutic categories that may overlap with Delta-Fly Pharma's interests.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse portfolio of pharmaceutical products, including for neurological conditions, a potential area of competition with Delta-Fly Pharma.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. specializes in pharmaceuticals for cardiovascular diseases and gynecology, areas where Delta-Fly Pharma might also be active.
Kyorin Pharmaceutical.
4569.TSE
Mkt Cap102.74B
Kyowa Hakko Kirin Co., Ltd. is involved in biopharmaceuticals and specialty drugs, competing in similar therapeutic areas as Delta-Fly Pharma.

About

Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Show more...
CEO
Kiyoshi Eshima
Employees
12
Country
Japan
ISIN
JP3549370009

Listings

TSE
JP
4598.TSE

0 Comments

Share your thoughts

FAQ

What is Delta-Fly Pharma stock price today?▼
The current price of 4598.TSE is ¥121 JPY — it has increased by +9.01% in the past 24 hours. Watch Delta-Fly Pharma stock price performance more closely on the chart.
What is Delta-Fly Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Delta-Fly Pharma stocks are traded under the ticker 4598.TSE.
Is Delta-Fly Pharma stock price growing?▼
4598.TSE stock has risen by +15.24% compared to the previous week, the month change is a +10% rise, over the last year Delta-Fly Pharma has showed a -79.77% decrease.
What is Delta-Fly Pharma market cap?▼
Today Delta-Fly Pharma has the market capitalization of 1.59B
When is the next Delta-Fly Pharma earnings date?▼
Delta-Fly Pharma is going to release the next earnings report on November 16, 2026.
What were Delta-Fly Pharma earnings last quarter?▼
4598.TSE earnings for the last quarter are -29.33 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Delta-Fly Pharma revenue for the last year?▼
Delta-Fly Pharma revenue for the last year amounts to 0 JPY.
What is Delta-Fly Pharma net income for the last year?▼
4598.TSE net income for the last year is -1.72B JPY.
How many employees does Delta-Fly Pharma have?▼
As of September 05, 2026, the company has 12 employees.
In which sector is Delta-Fly Pharma located?▼
Delta-Fly Pharma operates in the Health & Wellness sector.
When did Delta-Fly Pharma complete a stock split?▼
Delta-Fly Pharma has not had any recent stock splits.
Where is Delta-Fly Pharma headquartered?▼
Delta-Fly Pharma is headquartered in Tokushima, Japan.